(Q40587890)

21 September 2017

title

Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations (English)

1 reference

21 September 2017

Cost‐effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

3 January 2024

1 reference

1 reference

3

H. Groen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

author name string

TenVergert EM

2

1 reference

21 September 2017

van de Willige G

6

1 reference

21 September 2017

A. D. Stant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

E. M. TenVergert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

J. A. Jenner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

F. J. Nienhuis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

G. van de Willige

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

D. Wiersma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752032

3 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

21 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0447.2003.00102.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0447.2003.00102.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

Acta Psychiatrica Scandinavica

3 January 2024

published in

1 reference

21 September 2017

volume

107

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

361-368

1 reference

Change in Dutch mental health care: an evaluation.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Cognitive behaviour therapy with coping training for persistent auditory hallucinations in schizophrenia: a naturalistic follow-up study of the durability of effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Antipsychotic drug use patterns and the cost of treating schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Estimating the employment and earnings costs of mental illness: recent developments in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

The friction cost method for measuring indirect costs of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

Prevalence of long-term mental health care utilization in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Schizophrenia costs and treatment cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Effectiveness of cognitive therapy with coping training for persistent auditory hallucinations: a retrospective study of attenders of a psychiatric out-patient department

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Some Aspects of Family Interventions in Schizophrenia. II: Financial Considerations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Service use and costs of treating schizophrenia with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

An integrative treatment for patients with persistent auditory hallucinations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Towards a new approach for estimating indirect costs of disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Problems in conducting economic evaluations alongside clinical trials. Lessons from a study of case management for people with mental disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00102.X

7 January 2021

Medication noncompliance in schizophrenia: codification and update

6

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

Cost of illness studies for schizophrenia: components, benefits, results, and implications

3 January 2024

20

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

3 January 2024

25

1 reference

https://api.crossref.org/works/10.1034/J.1600-0447.2003.00102.X

3 January 2024

Identifiers

1 reference

21 September 2017

1 reference